We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Arrowhead Research
ARWR
$12B
| $615K | 0.01% |
33,500
| – | – |
|
752
1st Source
SRCE
$2.09B
| $610K | 0.01% |
+13,572
| New | +$617K |
|
|
FBC
753
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $605K | 0.01% |
18,392
-81,200
| -82% | -$2.54M |
|
|
MAGN
754
Magnera Corp
MAGN
$490M
| $596K | 0.01% |
+3,245
| New | +$547K |
|
755
Photronics
PLAB
$1.76B
| $592K | 0.01% |
62,672
-4,300
| -6% | -$43.6K |
|
756
Axcelis
ACLS
$3.94B
| $584K | 0.01% |
+29,036
| New | +$590K |
|
|
GTY
757
Getty Realty Corp
GTY
$2.12B
| $581K | 0.01% |
18,124
| – | – |
|
758
OneMain Financial
OMF
$7.08B
| $580K | 0.01% |
+18,280
| New | +$566K |
|
|
MZTI
759
The Marzetti Company
MZTI
$2.95B
| $573K | 0.01% |
+3,660
| New | +$589K |
|
760
Capital City Bank Group
CCBG
$890M
| $571K | 0.01% |
26,214
+7,790
| +42% | +$186K |
|
|
MRO
761
DELISTED
Marathon Oil Corporation
MRO
| $570K | 0.01% |
34,101
-30,500
| -47% | -$498K |
|
762
ATN International
ATNI
$364M
| $568K | 0.01% |
+10,066
| New | +$667K |
|
763
Anika Therapeutics
ANIK
$200M
| $567K | 0.01% |
+18,748
| New | +$642K |
|
|
PPLI
764
People Inc
PPLI
$3.15B
| $567K | 0.01% |
15,108
-7,218
| -32% | -$267K |
|
|
LGF.A
765
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $563K | 0.01% |
35,997
-151,499
| -81% | -$2.51M |
|
|
PVLA
766
Palvella Therapeutics
PVLA
$2.03B
| $562K | 0.01% |
+2,098
| New | +$498K |
|
767
Financial Institutions
FISI
$812M
| $557K | 0.01% |
20,504
| – | – |
|
|
MOFG
768
DELISTED
MidWestOne Financial Group
MOFG
| $547K | 0.01% |
20,080
+3,700
| +23% | +$105K |
|
|
SAFE
769
Safehold
SAFE
$1.19B
| $546K | 0.01% |
13,317
-10,046
| -43% | -$443K |
|
770
Arlo Technologies
ARLO
$1.51B
| $540K | 0.01% |
+130,813
| New | +$725K |
|
|
CWBC
771
Community West Bancshares
CWBC
$686M
| $537K | 0.01% |
27,456
-200
| -0.7% | -$3.92K |
|
772
LifeVantage
LFVN
$80.4M
| $534K | 0.01% |
37,346
+1,100
| +3% | +$16K |
|
773
Insight Enterprises
NSIT
$3.71B
| $523K | 0.01% |
+9,490
| New | +$478K |
|
774
Inseego
INSG
$114M
| $516K | 0.01% |
10,940
| – | – |
|
775
Sutro Biopharma
STRO
$398M
| $496K | 0.01% |
+4,353
| New | +$453K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.